Opioid crisis
December 12, 2019—Letter (PDF) urging House leaders to schedule a floor vote on S. 2740, the Over-the-Counter Drug Safety, Innovation, and Reform Act of 2019.
October 30, 2019—Letter (PDF) urging members of the Senate Committee on Health, Education, Labor, and Pensions to favorably report S. 2740, the Over-the-Counter Drug Safety, Innovation, and Reform Act of 2019.
June 18, 2019—Letter (PDF) thanking the House Committee on Oversight and Reform for holding a hearing on opioid treatment and supporting the Patient and Communities Act.
January 8, 2019—Letter (PDF) thanking House leaders for scheduling a floor vote on the Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019.
September 12, 2018—Letter (PDF) expressing support for the Senate substitute amendment to H.R. 6, the Opioid Crisis Response Act of 2018.
June 12, 2018—Letter (PDF) thanking House leaders for bringing several bills to the floor to address the opioid crisis
June 6, 2018—Letter (PDF) urging the Senate Committee on Finance to consider several proposals when marking up legislation to address the opioid crisis.
May 22, 2018—Letter (PDF) urging the House Judiciary Committee to consider several proposals when marking up legislation to address the opioid crisis.
May 22, 2018—Letter (PDF) informing the Senate Committee on Commerce, Science and Transportation about the ADA's new opioid prescribing policy.
May 16, 2018—Letter (PDF) urging the House Committee on Energy and Commerce to favorably report several bills to address the opioid crisis.
May 14, 2018—Letter (PDF) urging the House Ways and Means Committee to include dentists in any activities authorized by H.R. 5774, the Combatting Opioid Abuse for Care in Hospitals (COACH) Act.
April 23, 2018—Letter (PDF) Letter urging the Senate Committee on Health, Education, Labor, and Pensions to favorably report S. 2680, the Opioid Crisis response Act of 2018.
April 23, 2018—Letter (PDF) urging the Senate Committee on Health, Education, Labor, and Pensions to favorably report S. 2315, the Over-the-Counter Drug Safety, Innovation, and Reform Act.
March 30, 2018—Letter (PDF) informing the Department of Health and Human Services (HHS) about the ADA's new opioid prescribing policy.
March 26, 2018—Letter (PDF) informing the House Committee on Energy and Commerce about the ADA's new opioid prescribing policy.
March 26, 2018—Letter (PDF) informing the House Committee on Ways and Means about the ADA's new opioid prescribing policy.
March 26, 2018—Letter (PDF)informing the Senate Committee on Health, Education, Labor, and Pensions about the ADA's new opioid prescribing policy.
October 25, 2017—Statement (PDF) for the House Committee on Energy and Commerce hearing on "Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives," held October 25, 2017.
October 5, 2017—Statement (PDF) for the Senate Committee on Health, Education, Labor, and Pensions hearing on "The Federal Response to the Opioid Crisis," held October 5, 2017.
September 28, 2017—Letter (PDF) to Sens. Elizabeth Warren and Shelley Moore Capito regarding partial fill prescriptions for Schedule II controlled substances.
August 7, 2017—Letter (PDF) to Sen. Joe Manchin regarding dentistry's efforts to keep prescription opioid pain medications from becoming source of harm.
August 26, 2019—Comments (PDF) addressing how the Department of Health and Human Services (HHS) can balance legitimate patient access to controlled substances, including opioids, while also preventing diversion and abuse.
April 1, 2019—Comments (PDF) on the draft report of the Pain Management Best Practices Inter-Agency Task Force.
January 15, 2019—Comments (PDF) on the U.S. Preventive Services Task Force's (USPSTF) Draft Research Plan for Prevention of Opioid Use Disorder.
October 9, 2018—Letter (PDF) thanking the U.S. Surgeon General for issuing Facing Addiction in America: The Surgeon General's Spotlight on Opioids.
May 22, 2018—Letter (PDF) urging the Pain Management Best Practices Inter-Agency Task Force to address management of acute dental pain in its work.
March 30, 2018—Letter (PDF) informing the Department of Health and Human Services (HHS) about the ADA's new opioid prescribing policy.
March 16, 2018—Comments (PDF) in response to the Food and Drug Administration's (FDA) request for information on questions relevant to agency's Opioid Policy Steering Committee (OPSC).
July 17, 2017—Comments (PDF) on the Food and Drug Administration (FDA) draft Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioids.
September 6, 2016—Comments (PDF) responding to a Department of Health and Human Services (HHS) request for information about how federal opioid analgesic prescriber education and training activities can be improved.
Journalists may also contact the media relations department at:
Media Relations
312.440.2806
Email: mediarelations@ada.org